Search Results - "Yardley, M"

Refine Results
  1. 1

    Surgical and functional outcomes of two types of transcutaneous bone conduction implants by Scotta, G, Allam, A, Dimitriadis, P A, Wright, K, Yardley, M, Ray, J

    Published in Journal of laryngology and otology (01-12-2020)
    “…This study aimed to evaluate surgical and functional outcomes, in a tertiary referral centre, of two different types of semi-implantable transcutaneous bone…”
    Get more information
    Journal Article
  2. 2

    Soft-tissue outcomes following implantation of different types of bone conduction hearing devices in a single centre by Ray, J, Lau, K, Moraleda, J, Yardley, M, Dawoud, M, Dimitriadis, P A

    Published in Journal of laryngology and otology (01-12-2019)
    “…To compare soft-tissue complications following implantation of different bone conduction hearing devices. Adults who underwent implantation of different bone…”
    Get more information
    Journal Article
  3. 3

    Effect of High-Intensity Interval Training in De Novo Heart Transplant Recipients - 3-year Results from the HITTS Randomized Controlled Trial by Rolid, K., Andreassen, A.K., Yardley, M., Bjørkelund, E., Authen, A.R., Grov, I., Gude, E., Broch, K., Gullestad, L., Nytrøen, K.

    “…The HITTS study (High -intensity Interval Training in de novo Heart Transplant Recipients in Scandinavia) is a randomized controlled trial designed to assess…”
    Get full text
    Journal Article
  4. 4

    Benefits of High-Intensity Interval Training in a Young and in an Older De Novo Heart Transplant Recipient- Cases from the HITTS Study by Rolid, K., Andreassen, A.K., Yardley, M., Bjørkelund, E., Authen, A.R., Grov, I., Gude, E., Karason, K., Broch, K., Gullestad, L., Nytrøen, K.

    “…High-intensity interval training (HIT) is an effective method to increase exercise capacity in de novo heart transplant recipients, as shown in the recently…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models by Yardley, Megan M., Ray, Lara A.

    Published in Addiction biology (01-05-2017)
    “…Development of effective treatments for alcohol use disorder (AUD) represents an important public health goal. This review provides a summary of completed…”
    Get full text
    Journal Article
  8. 8

    Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity by Cservenka, Anita, Yardley, Megan M., Ray, Lara A.

    Published in The American journal on addictions (01-08-2017)
    “…Background and Objectives Pharmacogenetic studies of alcohol use disorder (AUD) have suggested that the efficacy of treatments for AUD is, in part, influenced…”
    Get full text
    Journal Article
  9. 9

    Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter? by Ray, Lara A., Bujarski, Spencer, Yardley, Megan M., Roche, Daniel J. O., Hartwell, Emily E.

    “…Background: Medication development for alcoholism typically includes experimental pharmacology studies with non-treatment-seeking individuals with alcohol use…”
    Get full text
    Journal Article
  10. 10

    Contribution of P2X4 Receptors to Ethanol Intake in Male C57BL/6 Mice by Wyatt, Letisha R., Finn, Deborah A., Khoja, Sheraz, Yardley, Megan M., Asatryan, Liana, Alkana, Ronald L., Davies, Daryl L.

    Published in Neurochemical research (01-06-2014)
    “…P2X receptors (P2XRs) are a family of cation-permeable ligand-gated ion channels activated by synaptically released extracellular adenosine 5′-triphosphate…”
    Get full text
    Journal Article
  11. 11

    Early post-operative morbidity following tonsillectomy in children: implications for day surgery by Panarese, A, Clarke, R W, Yardley, M P

    Published in Journal of laryngology and otology (01-12-1999)
    “…Adenotonsillectomy and tonsillectomy are amongst the most commonly performed surgical procedures. In our prospective study we looked at early post-operative…”
    Get more information
    Journal Article
  12. 12

    Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers by Yardley, Megan M., Mirbaba, Michael M., Ray, Lara A.

    Published in CNS drugs (01-10-2015)
    “…There is a high prevalence of comorbid tobacco use and alcohol use disorder (AUD), affecting more than 6 million people in the US. Globally, tobacco and…”
    Get full text
    Journal Article
  13. 13

    Ivermectin reduces alcohol intake and preference in mice by Yardley, Megan M., Wyatt, Letisha, Khoja, Sheraz, Asatryan, Liana, Ramaker, Marcia J., Finn, Deborah A., Alkana, Ronald L., Huynh, Nhat, Louie, Stan G., Petasis, Nicos A., Bortolato, Marco, Davies, Daryl L.

    Published in Neuropharmacology (01-08-2012)
    “…The high rate of therapeutic failure in the management of alcohol use disorders (AUDs) underscores the urgent need for novel and effective strategies that can…”
    Get full text
    Journal Article
  14. 14

    A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder by Roche, Daniel J. O., Yardley, Megan M., Lunny, Katy F., Louie, Stan G., Davies, Daryl L., Miotto, Karen, Ray, Lara A.

    “…Background Ivermectin (IVM) is an antiparasitic agent that has been shown to reduce alcohol intake in mice, suggesting IVM as a potential treatment for alcohol…”
    Get full text
    Journal Article
  15. 15

    Multiday administration of ivermectin is effective in reducing alcohol intake in mice at doses shown to be safe in humans by Yardley, Megan M, Neely, Michael, Huynh, Nhat, Asatryan, Liana, Louie, Stan G, Alkana, Ronald L, Davies, Daryl L

    Published in Neuroreport (10-09-2014)
    “…Ivermectin (IVM), an FDA approved anthelmintic agent, can significantly reduce ethanol intake in mice following acute administration. The current study…”
    Get full text
    Journal Article
  16. 16

    Oral delivery of ivermectin using a fast dissolving oral film: Implications for repurposing ivermectin as a pharmacotherapy for alcohol use disorder by Yardley, Megan M, Huynh, Nhat, Rodgers, Kathleen E, Alkana, Ronald L, Davies, Daryl L

    Published in Alcohol (Fayetteville, N.Y.) (01-09-2015)
    “…Abstract Individuals suffering from an alcohol-use disorder (AUD) constitute a major health concern. Preclinical studies in our laboratory show that acute and…”
    Get full text
    Journal Article
  17. 17

    Pharmacological insights into the role of P2X4 receptors in behavioural regulation: lessons from ivermectin by Bortolato, Marco, Yardley, Megan M., Khoja, Sheraz, Godar, Sean C., Asatryan, Liana, Finn, Deborah A., Alkana, Ronald L., Louie, Stan G., Davies, Daryl L.

    “…Purinergic ionotropic P2X receptors are a family of cation-permeable channels that bind extracellular adenosine 5′-triphosphate. In particular, convergent…”
    Get full text
    Journal Article
  18. 18

    Effect of conductive hearing loss on the vestibulo-collic reflex by Bath, A. P., Harris, N., Mcewan, J., Yardley, M. P.

    Published in Clinical otolaryngology (01-06-1999)
    “…The vestibulo‐collic reflex represents a promising test for evaluating the integrity of otolith function. We have investigated the threshold of this response…”
    Get full text
    Journal Article
  19. 19
  20. 20